Xconomy’s Digital Events →
New York-based Intercept Pharmaceuticals is developing drugs for chronic liver diseases.
Sponsored · Whitepaper
What the most successful life sciences fundraising pitch decks all have in common
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders
© 2007-2021, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.